Delayed hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 2580006)

Published in J Immunol on May 01, 1985

Authors

R D Schrier, G Y Ishioka, L I Pizer, J W Moorhead

Articles by these authors

Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A (1986) 8.45

Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc Natl Acad Sci U S A (1984) 4.56

Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science (1985) 3.69

Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen. J Exp Med (1979) 3.35

Effect of tunicamycin on herpes simplex virus glycoproteins and infectious virus production. J Virol (1980) 2.99

Biochemical bases for the antimetabolite action of L-serine hydroxamate. J Bacteriol (1971) 2.51

Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen. J Immunol (1982) 2.36

Tolerance and contact sensitivity to DNFB in mice. 3. Transfer of tolerance with "suppressor T cells". J Immunol (1974) 2.25

Tolerance and contact sensitivity to DNFB in mice. VI. Inhibition of afferent sensitivity by suppressor T cells in adoptive tolerance. J Immunol (1976) 2.22

Tolerance and contact sensitivity to DNFB in mice. I. In vivo detection by ear swelling and correlation with in vitro cell stimulation. J Immunol (1974) 2.18

Herpes simplex virus immediate early infected-cell polypeptide 4 binds to DNA and promotes transcription. Proc Natl Acad Sci U S A (1986) 2.07

Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. J Neuropathol Exp Neurol (1986) 1.94

Tolerance and contact sensitivity to DNFA in mice. VIII. Identification of distinct T cell subpopulations that mediate in vivo and in vitro manifestations of delayed hypersensitivity. J Immunol (1978) 1.92

Herpes simplex virus-induced changes in cellular and adenovirus RNA metabolism in an adenovirus type 5-transformed human cell line. J Virol (1982) 1.90

Propagation of antigen-specific T cell helper function in vitro. J Immunol (1979) 1.88

Abortive infection of Escherichia coli strain W by T2 bacteriophage. J Mol Biol (1968) 1.84

The mechanism of end product inhibition of serine biosynthesis. I. Purification and kinetics of phosphoglycerate dehydrogenase. J Biol Chem (1968) 1.80

Suppressive mechanisms involving sensitization and tolerance in contact allergy. Immunol Rev (1980) 1.72

Phospholipid synthesis in Escherichia coli infected with T4 bacteriophages. J Virol (1968) 1.66

Corticosteroids and lymphoid cells in vitro. I. Hydrocortisone lysis of human, guinea pig, and mouse thymus cells. J Lab Clin Med (1971) 1.66

Purification and regulatory properties of the biosynthetic L-glycerol 3-phosphate dehydrogenase from Escherichia coli. J Biol Chem (1969) 1.63

Herpesvirus glycoprotein synthesis and insertion into plasma membranes. J Virol (1982) 1.61

Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide. J Exp Med (2001) 1.57

Soluble factors in tolerance and contact sensitivity to 2,4-dinitrofluorobenzene in mice. I. Suppression of contact sensitivity by soluble suppressor factor released in vitro by lymph node cell populations containing specific suppressor cells. J Immunol (1977) 1.55

Control of experimental contact sensitivity. Adv Immunol (1980) 1.54

Regulation of cell-mediated immunity in cryptococcosis. II. Characterization of first-order T suppressor cells (Ts1) and induction of second-order suppressor cells. J Immunol (1983) 1.52

A mutant of Escherichia coli defective in phosphatidic acid synthesis. Biochem Biophys Res Commun (1969) 1.52

Regulation of phospholipid synthesis in Escherichia coli by guanosine tetraphosphate. J Bacteriol (1973) 1.51

The ICP4 binding sites in the herpes simplex virus type 1 glycoprotein D (gD) promoter are not essential for efficient gD transcription during virus infection. J Virol (1992) 1.51

Regulation of one-carbon biosynthesis and utilization in Escherichia coli. J Bacteriol (1974) 1.46

Effect of serine hydroxamate on the growth of Escherichia coli. J Bacteriol (1971) 1.46

Effect of prophage W on the propagation of bacteriophages T2 and T4. J Virol (1968) 1.46

Thymus-derived lymphocytes and hydrocortisone: identification of subsets of theta-bearing cells and redistribution to bone marrow. Cell Immunol (1972) 1.43

An antigen encoded by the latency-associated transcript in neuronal cell cultures latently infected with herpes simplex virus type 1. J Virol (1991) 1.41

ICP4-binding sites in the promoter and coding regions of the herpes simplex virus gD gene contribute to activation of in vitro transcription by ICP4. J Virol (1989) 1.40

Anti-immunoglobulin stimulation of murine lymphocytes. I. Age dependency of the proliferative response. J Immunol (1976) 1.39

Immunologic reactions to haptens on autologous carriers. I. Participation of both thymus-derived and bone marrow-derived cells in the secondary in vitro response. J Exp Med (1973) 1.36

The effect of herpes virus infection on mRNA in polyoma virus transformed cells. Virology (1976) 1.36

Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein. J Immunol (1983) 1.34

Soluble factors in tolerance and contact sensitivity to 2,4-dinitrofluorobenzene in mice. III. Histocompatibility antigens associated with the hapten dinitrophenol serve as target molecules on 2,4-dinitrofluorobenzene-immune T cells for soluble suppressor factor. J Exp Med (1979) 1.28

Characterization of a phosphoprotein associated with the SS-B/La nuclear antigen in adenovirus-infected and uninfected KB cells. Mol Cell Biol (1983) 1.23

Tolerance and suppression of immunity to herpes simplex virus: different presentations of antigens induce different types of suppressor cells. Infect Immun (1983) 1.23

Phosphatidic acid synthesis in Escherichia coli. J Bacteriol (1969) 1.22

Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus. J Infect Dis (1986) 1.22

Activation of second-messenger pathways reactivates latent herpes simplex virus in neuronal cultures. Virology (1992) 1.20

Subpopulations of mouse T lymphocytes. I. "Thymidine suicide" of a major proliferating, PHA-responsive cell population present in spleen but not in lymph node. J Immunol (1974) 1.19

Tolerance: two pathways of negative immunoregulation in contact sensitivity to DNFB. Cold Spring Harb Symp Quant Biol (1977) 1.19

Soluble factors in tolerance and contact sensitivity to DNFB in mice. II. Genetic requirements for suppression of contact sensitivity by soluble suppressor factor. J Immunol (1977) 1.19

Regulation of cell mediated immunity by antibodies: possible role of anti-receptor antibodies in the regulation of contact sensitivity to DNFB in mice. J Immunol (1979) 1.19

Role for DNA-protein interaction in activation of the herpes simplex virus glycoprotein D gene. J Virol (1988) 1.18

Immunity tolerance to a hapten (NIP) coupled to an isologous carrier (mouse gamma globulin). J Exp Med (1972) 1.18

Serine biosynthesis and regulation in Haemophilus influenzae. J Bacteriol (1969) 1.17

Metabolic consequences of limited phospholipid synthesis in Escherichia coli. J Biol Chem (1974) 1.16

T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis. Eur J Immunol (1994) 1.16

Recent clinical isolates of cytomegalovirus suppress human cytomegalovirus-specific human leukocyte antigen-restricted cytotoxic T-lymphocyte activity. J Virol (1986) 1.13

Effect of trimethoprim on macromolecular synthesis in Escherichia coli. J Bacteriol (1971) 1.13

The mechanism of end product inhibition of serine biosynthesis. II. Optical studies of phosphoglycerate dehydrogenase. J Biol Chem (1968) 1.10

Transient kinetic and deuterium isotope effect studies on the catalytic mechanism of phosphoglycerate dehydrogenase. J Biol Chem (1977) 1.08

Characterization of RNA synthesized in isolated nuclei of herpes simplex virus type 1-infected KB cells. J Virol (1980) 1.07

Regulation of transcription in vitro from herpes simplex virus genes. J Virol (1986) 1.06

Regulation of phosphoglycerate dehydrogenase levels and effect on serine synthesis in Escherichia coli K-12. J Bacteriol (1980) 1.05

Tolerance and contact sensitivity to DNFB in mice. II. Specific in vitro stimulation with a hapten, 2,4-dinitrobenzene sulfonic acid (DNB-SO3Na). J Immunol (1974) 1.04

The biosynthetic L-alpha-glycerol phosphate dehydrogenase of E. coli. Biochem Biophys Res Commun (1968) 1.04

Abortive infection of Shigella dysenteriae P2 by T2 bacteriophage. J Virol (1969) 1.03

Antigen receptors on murine T lymphocytes in contact sensitivity. I. Functional inhibition of effector T cells by monovalent 2,4-dinitrophenol: implication for a two-receptor model. J Exp Med (1981) 1.02

Definition of a DQ3.1-specific binding motif. J Immunol (1994) 1.01

Herpesvirus infection alters the steady-state levels of cellular polyadenylated RNA in polyoma virus-transformed BHK cells. J Virol (1982) 1.01

The metabolism of serine and glycine in mutant lines of Chinese hamster ovary cells. Arch Biochem Biophys (1980) 1.00

Efficient induction of immediate tolerance to contact sensitivity by hapten-modified spleen cells requires Ia+ cells compatible with recipient. Nature (1979) 0.99

Delayed hypersensitivity to herpes simplex virus: murine model. Infect Immun (1982) 0.99

Characterization of a mutant of E. coli with elevated levels of seryl-tRNA synthetase. Biochem Biophys Res Commun (1972) 0.98

Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease. J Clin Microbiol (2001) 0.98

Effect of serine hydroxamate on phospholipid synthesis in Escherichia coli. J Bacteriol (1973) 0.97

RNAs transcribed from a 3.6-kilobase SmaI fragment of the short unique region of the herpes simplex virus type 1 genome. J Virol (1983) 0.97

Transient kinetic studies on the allosteric transition of phosphoglycerate dehydrogenase. J Biol Chem (1977) 0.96

cDNA cloning and immunological characterization of the rye grass allergen Lol p I. J Biol Chem (1990) 0.95

Anti-immunoglobulin stimulation of murine lymphocytes. V. Age-related decline in Fc receptor-mediated immunoregulation. J Immunol (1978) 0.95

Antigen receptors on murine T lymphocytes in contact sensitivity. III. Mechanism of negative feedback regulation by auto-anti-idiotypic antibody. J Exp Med (1982) 0.93

Increased proliferative response of human peripheral blood lymphocytes to anti-immunoglobulin antibodies in elderly people. Clin Immunol Immunopathol (1978) 0.93

Replication, latent infection, and reactivation in neuronal culture with a herpes simplex virus thymidine kinase-negative mutant. Virology (1992) 0.92

The mechanism of end product inhibition of serine biosynthesis. IV. Subunit structure of phosphoglycerate dehydrogenase and steady state kinetic studies of phosphoglycerate oxidation. J Biol Chem (1974) 0.92

Anti-immunoglobulin stimulation of murine lymphocytes. II. Identification of cell surface target molecules and requirements for cross-linkage. J Immunol (1976) 0.92

Tolerance to contact hypersensitivity. Contemp Top Immunobiol (1976) 0.91

CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy. AIDS (2000) 0.90

Comparative enzymology of serine biosynthesis in mammalian systems. Biochim Biophys Acta (1966) 0.90

Herpesvirus infection modifies adenovirus RNA metabolism in adenovirus type 5-transformed cells. J Virol (1978) 0.89

Serine biosynthesis and its regulation in Bacillus subtilis. J Bacteriol (1972) 0.89

Allogeneic grafts of fetal dopamine neurons: immunological reactions following active and adoptive immunizations. Brain Res (1995) 0.89

Detection of the latency-associated transcript in neuronal cultures during the latent infection with herpes simplex virus type 1. Virology (1991) 0.88

Regulatory properties of purified 3-phosphoglycerate dehydrogenase from Bacillus subtilis. Eur J Biochem (1975) 0.88

Correlation between degradation of bacteriophage T2 deoxyribonucleic acid and the resistance of Escherichia coli to infection. J Virol (1969) 0.88

Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects. J Infect Dis (2000) 0.88

DNP-specific/class I MHC-restricted suppressor molecules bear determinants of the T cell receptor alpha- and beta-chains. The V beta 8+ chain dictates restriction to either K or D. J Immunol (1990) 0.87

Soluble factors in tolerance and contact sensitivity to 2,4-dinitro-fluorobenzene in mice. IX. A monoclonal T cell suppressor molecule is structurally and serologically related to the alpha/beta T cell receptor. J Immunol (1988) 0.87